查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
双特异性抗体市场:各产品类型，各用途，各适应症，各国，各地区- 产业分析，市场规模，市场占有率，2023-2030年预测
市场调查报告书
商品编码
1320179

双特异性抗体市场:各产品类型，各用途，各适应症，各国，各地区- 产业分析，市场规模，市场占有率，2023-2030年预测

Bispecific Antibody Market with COVID-19 Impact Analysis, By Product Type, By Application, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 258 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年双特异性抗体市场规模将达6.309亿美元，2023年至2030年复合年增长率为8.3%

双特异性抗体市场 - 市场动态：

全球癌症负担的增加和有效治疗方法的缺乏预计将推动双特异性抗体市场的成长。

癌症是一个重大的全球健康问题，其负担持续增加。儘管癌症治疗和护理取得了进展，但缺乏治癒性治疗仍然令人担忧。一种有前景的癌症免疫治疗方法是使用双特异性抗体。据世界卫生组织 (WHO) 称，癌症是全球头号死亡原因，预计 2020 年将促使近 1,000 万人死亡。双特异性抗体的优点是能够同时或依序锁定多个抗原，可以与化疗、小分子、检查点抑制剂等免疫调节药物合併使用。研发活动的增加可能会创造市场成长机会。然而，与药物开发相关的高成本阻碍了市场成长。

双特异性抗体市场 - 主要见解：

  • 由于永续成长意识不断增强，双特异性抗体产业预计将大幅成长
  • 按产品类型划分，癌症将在 2022 年占最大的市场占有率
  • 有迹象表明，Katumaxomab将成为2022年的主要类型。
  • 按地区划分，北美将成为 2022 年收入的主要市场

双特异性抗体市场 - 区隔分析：

双特异性抗体的全球市场根据适应症、产品类型、用途和地区进行区隔。

市场依适应症分为三类：癌症、发炎/自体免疫疾病和其他。癌症在市场上占主导地位。双特异性抗体作为免疫治疗剂已显示出巨大的潜力，有可能增强人体对癌细胞的免疫反应。双特异性抗体用于特异性靶向癌细胞或修饰免疫细胞以更有效地识别和对抗癌细胞。

市场依产品类型分为两类：Blinatumomab、Catumaxomab、Duligotumab 等。卡妥索单抗在市场上占主导地位，预计在预测期内将保持其主导地位。卡妥马索单抗是已用于癌症治疗的双特异性抗体的一个具体例子。Katumaxomab 是一种三功能抗体，开发用于治疗恶性腹水（癌细胞在腹腔积聚且体液积聚的病症）。

市场依应用分为两类：医院、专科诊所和其他。医院处于癌症治疗的最前沿，通常在提供双特异性抗体等尖端药物方面发挥关键作用。专注于癌症治疗或免疫疗法的专科诊所也可能参与双特异性抗体的施用。

双特异性抗体市场 - 地理洞察：

从地理来看，该市场遍布北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。这些地区根据其经营所在的国家进一步划分。北美因其大量癌症（包括肺癌、前列腺癌、乳腺癌和子宫颈癌）而在双特异性抗体市场占主导地位。这些癌症是双特异性抗体的潜在标靶，并且正在推动该地区对此类疗法的需求。美国国家癌症研究所预测，2020年，美国将有1,806,590人新诊断出癌症，606,520人将死于癌症。此外，由于对标靶和个人化治疗的需求不断增长以及新的双特异性抗体形式和技术的出现，预计欧洲和亚太地区对双特异性抗体市场的需求将增加。

双特异性抗体市场 - 竞争格局：

双特异性抗体市场竞争激烈，每家公司都以争夺市场占有率和监管批准为目标。双特异性抗体的开发引起了製药和生物技术行业的极大兴趣，市场竞争日益加剧。许多公司正在资助研究和开发，以创造针对多种癌症和其他疾病的新型双特异性抗体候选物。随着越来越多的研究支持双特异性抗体的实用性，人们对开发和使用这些治疗方法治疗各种类型癌症的兴趣与日俱增。一些製药和生物技术公司正在投资研发以产生自己的双特异性抗体志工。这促使越来越多的公司竞相将有效的双特异性抗体疗法推向市场。公司正在透过优化双特异性抗体设计、改进製造流程以及探索联合疗法来提高疗效，从而使他们的产品脱颖而出。例如，安进 (Amgen) 和 Xencor, Inc. 最近宣布了一项研究和许可协议，以开发和商业化癌症免疫疗法和炎症的新疗法。此次合作将 Amgen 在标靶发现和蛋白质治疗方面的能力与 Xencor 的 XmAb 双特异性技术平台结合。

目录

第1章 双特异性抗体市场概要

  • 调查范围
  • 市场估计年数

第2章 摘要整理

  • 市场明细
  • 竞争考察

第3章 双特异性抗体的主要市场趋势

  • 双特异性抗体推动市场要素
  • 双特异性抗体阻碍市场要素
  • 双特异性抗体市场机会
  • 双特异性抗体市场今后趋势

第4章 双特异性抗体产业的调查

  • PEST分析
  • 波特的五力分析
  • 成长预测的製图
  • 法规结构的分析

第5章 双特异性抗体市场:COVID-19影响分析

  • COVID-19前的影响分析
  • COVID-19后的影响分析

第6章 双特异性抗体市场形势

  • 双特异性抗体市场占有率分析，2022年
  • 各主要製造商的明细资料
    • 现有企业的分析
    • 新兴企业的分析

第7章 双特异性抗体市场-各产品类型

  • 概要
    • 各产品类型的市场区隔占有率分析
    • Blinatumomab
    • Catumaxomab
    • Duligotumab
    • 其他

第8章 双特异性抗体市场- 各用途

  • 概要
    • 各用途的市场区隔占有率分析
    • 医院
    • 专门诊所
    • 其他

第9章 双特异性抗体市场- 各适应症

  • 概要
    • 各适应症各市场区隔占有率分析
    • 癌症
    • 发炎性·自体免疫疾病
    • 其他

第10章 双特异性抗体市场-各地区

  • 简介
  • 北美
    • 概要
    • 主要製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概要
    • 主要製造商
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区(APAC)
    • 概要
    • 主要製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 其他
  • 南美
    • 概要
    • 主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概要
    • 主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第11章 主要供应商分析- 双特异性抗体产业

  • 竞争仪表板
  • 企业简介
    • Genmab
    • Merus
    • Chugai Pharmaceutical
    • Ablynx
    • Genentech
    • Jounce Therapeutics
    • Affimed Therapeutics
    • Eli Lilly
    • AstraZeneca(MedImmune)
    • Neovii Biotech
    • Pieris
    • Adimab
    • Immunomedics
    • Roche
    • Amgen
    • Sanofi
    • Emergent BioSolutions
    • NovImmune SA
    • Regeneron Pharmaceuticals
    • EMD Serono
    • OncoMed Pharmaceuticals
    • MacroGenicsC

第12章 分析师的全方位展望

Product Code: ANV1490

REPORT HIGHLIGHT

Bispecific Antibody Market size was valued at USD 630.9 Million in 2022, expanding at a CAGR of 8.3% from 2023 to 2030.

Bispecific antibodies aim to treat multi-layered, complex diseases by engaging two disease targets with one molecule. They are synthetic hybrid molecules having two separate binding domains that target two unique antigens, as opposed to natural antibodies, which have two targeting arms that attach to the same target antigen. Bispecific antibodies are typically not found in nature but are instead created using recombinant DNA techniques or cell fusion. By focusing on two distinct disease pathways, bispecific antibodies have the potential to increase therapeutic efficacy in the treatment of complicated human diseases.

Bispecific Antibody Market- Market Dynamics:

The rising global burden of cancer and the unavailability of effective curing drugs possess are expected to propel the growth of the Bispecific Antibody Market.

Cancer is a significant global health challenge, and its burden continues to rise. While advances in cancer treatment and care have been made, the lack of viable curative treatments remains a concern. One promising approach to cancer immunotherapy is the use of Bispecific Antibodies. According to the world health organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Bispecific antibodies have the benefit of being able to target numerous antigens simultaneously and sequentially, and they can be employed in conjunction with chemotherapy, small compounds, and immunomodulatory medicines like checkpoint inhibitors. An increase in the number of research and development activities can provide growth opportunities for the market. However, the High cost associated with drug development hampers the market growth.

Bispecific Antibody Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Bispecific Antibody market is estimated to grow annually at a CAGR of around 8.3% over the forecast period (2023-2030)
  • The Bispecific Antibody industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Product Type segmentation, Cancer was predicted to show maximum market share in the year 2022
  • Based on Indication segmentation, Catumaxomab was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Bispecific Antibody Market- Segmentation Analysis:

The Global Bispecific Antibody Market is segmented on the basis of Indication, Product Type, Application, and Region.

The market is divided into three categories based on Indication: Cancer, Inflammatory & Autoimmune Disorders, and Others. Cancer dominates the market. Bispecific antibodies have shown tremendous potential as immunotherapeutic medicines with the potential to enhance the body's immune response against cancer cells. They can be employed to specifically target cancer cells or modify immune cells to more effectively recognize and battle cancer cells.

The market is divided into two categories based on Product Type: Blinatumomab, Catumaxomab, Duligotumab, and Others. Catumaxomab dominates the market and is likely to maintain its dominance during the forecast period. Catumaxomab is a specific example of a bispecific antibody that has been used in cancer treatment. It is a trifunctional antibody that was developed for the treatment of malignant ascites, a condition where cancerous cells accumulate in the abdominal cavity and lead to fluid buildup.

The market is divided into two categories based on application: Hospitals, Specialty Clinics, and Others. Hospitals are on the cutting edge of cancer care and frequently play a crucial part in delivering cutting-edge medicines like bispecific antibodies. Specialty clinics that focus on cancer care or immunotherapy may also be involved in administering bispecific antibodies.

Bispecific Antibody Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America dominates the Bispecific Antibody market due to the highest numbers of several cancers such as lung cancer, prostate cancer, breast cancer, and cervical cancer. These cancers are potential targets for bi-specific antibodies, driving the demand for such therapies in the region. National cancer institute predicted that in 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease. Furthermore, Europe and Asia Pacific are projected to demand for Bispecific Antibody Market, due to the growing demand for targeted and personalized therapies and the emergence of novel bispecific antibody formats and technologies.

Bispecific Antibody Market- Competitive Landscape:

Bispecific antibody markets are highly competitive, with businesses aiming for market share and regulatory approvals for their goods. Bispecific antibody development has attracted significant interest from the pharmaceutical and biotechnology industries, raising market competition. Numerous companies have been funding research and development to create novel bispecific antibody candidates that focus on various cancers and other diseases. As more research supports the benefits of Bispecific antibodies, there is a growing interest in developing and utilizing these therapies for various types of cancer. Several pharmaceutical companies and biotechnology firms are investing in research and development to create their own Bispecific antibody applicants. This has led to an increase in the number of companies competing to bring effective Bispecific Antibody therapies to the market. Companies are striving to differentiate their products by optimizing the design of Bispecific Antibody, improving manufacturing processes, and exploring combination therapies to enhance their effectiveness. For Instance, Amgen and Xencor, Inc. announced nowadays that the two companies have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation. The research collaboration brings together Amgen's capabilities in target discovery and protein therapeutics with Xencor's XmAb bispecific technology platform.

Recent Developments:

Dec. 19, 2022, Biogen Inc. announced that it has reached an agreement with Genentech, a member of the Roche Group, related to the commercialization and sharing of economics for glofitamab. Under the terms of the agreement, Biogen will have no payment obligations and will receive tiered royalties on potential net sales of glofitamab within the United States as part of the company's long-standing collaboration on antibodies targeting CD20.

Key features of the study:

  • This proposed research study on the Bispecific Antibody market provides market size (US$ Million), compound annual growth rate (CAGR %), and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Bispecific Antibody market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Bispecific Antibody market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Bispecific Antibody market
  • Impact of COVID-19 on Bispecific Antibody market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Bispecific Antibody market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Bispecific Antibody market, we have also included competitive landscape and key innovator analysis for the Bispecific Antibody market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Bispecific Antibody market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Bispecific Antibody market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BISPECIFIC ANTIBODY MARKET KEY PLAYERS

  • Genmab
  • Merus
  • Chugai Pharmaceutical
  • Ablynx
  • Genentech
  • Jounce Therapeutics
  • Affimed Therapeutics
  • Eli Lilly
  • AstraZeneca (MedImmune)
  • Neovii Biotech
  • Pieris
  • Adimab
  • Immunomedics
  • Roche
  • Amgen
  • Sanofi
  • Emergent BioSolutions
  • NovImmune SA
  • Regeneron Pharmaceuticals
  • EMD Serono
  • OncoMed Pharmaceuticals
  • MacroGenicsC

GLOBAL BISPECIFIC ANTIBODY MARKET, BY INDICATION

  • Cancer
  • Inflammatory & Autoimmune Disorder
  • Others

GLOBAL BISPECIFIC ANTIBODY MARKET, BY PRODUCT TYPE

  • Blinatumomab
  • Catumaxomab
  • Duligotumab
  • Others

GLOBAL BISPECIFIC ANTIBODY MARKET, BY END-USER

  • Hospital
  • Specialty Clinics
  • Others

GLOBAL BISPECIFIC ANTIBODY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bispecific Antibody Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bispecific Antibody Market Snippet by Product Type
    • 2.1.2. Bispecific Antibody Market Snippet by Application
    • 2.1.3. Bispecific Antibody Market Snippet by Indication
    • 2.1.4. Bispecific Antibody Market Snippet by Country
    • 2.1.5. Bispecific Antibody Market Snippet by Region
  • 2.2. Competitive Insights

3. Bispecific Antibody Key Market Trends

  • 3.1. Bispecific Antibody Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bispecific Antibody Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bispecific Antibody Market Opportunities
  • 3.4. Bispecific Antibody Market Future Trends

4. Bispecific Antibody Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bispecific Antibody Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Bispecific Antibody Market Landscape

  • 6.1. Bispecific Antibody Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bispecific Antibody Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Blinatumomab
    • 7.1.3. Catumaxomab
    • 7.1.4. Duligotumab
    • 7.1.5. Others

8. Bispecific Antibody Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hospital
    • 8.1.3. Specialty Clinics
    • 8.1.4. Others

9. Bispecific Antibody Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 9.1.2. Cancer
    • 9.1.3. Inflammatory & Autoimmune Disorder
    • 9.1.4. Others

10. Bispecific Antibody Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Bispecific Antibody Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Bispecific Antibody Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Bispecific Antibody Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Bispecific Antibody Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Bispecific Antibody Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bispecific Antibody Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Genmab
    • 11.2.2. Merus
    • 11.2.3. Chugai Pharmaceutical
    • 11.2.4. Ablynx
    • 11.2.5. Genentech
    • 11.2.6. Jounce Therapeutics
    • 11.2.7. Affimed Therapeutics
    • 11.2.8. Eli Lilly
    • 11.2.9. AstraZeneca (MedImmune)
    • 11.2.10. Neovii Biotech
    • 11.2.11. Pieris
    • 11.2.12. Adimab
    • 11.2.13. Immunomedics
    • 11.2.14. Roche
    • 11.2.15. Amgen
    • 11.2.16. Sanofi
    • 11.2.17. Emergent BioSolutions
    • 11.2.18. NovImmune SA
    • 11.2.19. Regeneron Pharmaceuticals
    • 11.2.20. EMD Serono
    • 11.2.21. OncoMed Pharmaceuticals
    • 11.2.22. MacroGenicsC

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bispecific Antibody Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Bispecific Antibody Market, by Product Type 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Bispecific Antibody Market, by Application 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Bispecific Antibody Market, by Indication 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bispecific Antibody Market, by Region 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)